Department of Medicine, University of Washington School of Medicine, Seattle 98159-7710, USA.
Circulation. 2010 Apr 13;121(14):1637-44. doi: 10.1161/CIRCULATIONAHA.109.914945. Epub 2010 Mar 29.
The mechanisms of atherosclerotic plaque rupture are poorly understood. Urokinase-type plasminogen activator (uPA) is expressed at elevated levels by macrophages in advanced human plaques. Patients with evidence of increased plasminogen activation have an elevated risk of major cardiovascular events. We used atherosclerotic mice to test the hypothesis that increased macrophage uPA expression in advanced plaques would cause histological features similar to those in ruptured human plaques.
Bone marrow from transgenic mice with increased macrophage uPA expression or nontransgenic controls (all apolipoprotein E-null [Apoe(-/-)]) was transplanted into 35-week-old Apoe(-/-) recipients, and innominate lesions and aortas were examined 8 to 13 weeks later. Donor macrophages accumulated in innominate lesions adjacent to plaque caps and in aortas, increasing uPA expression at both sites. Recipients of uPA-overexpressing macrophages had an increased prevalence of intraplaque hemorrhage (61% versus 13%; P=0.002) as well as increased lesion fibrin staining and fibrous cap disruption (P=0.06 for both). Transplantation of uPA-overexpressing macrophages increased aortic matrix metalloproteinase activity (40%; P=0.02). This increase was independent of matrix metalloproteinase-9.
In advanced plaques of Apoe(-/-) mice, macrophage uPA overexpression causes intraplaque hemorrhage and fibrous cap disruption, features associated with human plaque rupture. uPA overexpression also increases vascular matrix metalloproteinase activity. These data provide a mechanism that connects macrophage uPA expression, matrix metalloproteinase activity, and plaque rupture features in mice. The data also suggest that elevated plaque plasminogen activator expression and plasminogen activation in humans may be causally linked to plaque rupture and cardiovascular events.
动脉粥样硬化斑块破裂的机制尚未完全阐明。尿激酶型纤溶酶原激活物(uPA)在人类晚期斑块中的巨噬细胞中呈高水平表达。有证据表明纤溶酶原激活增加的患者发生主要心血管事件的风险增加。我们使用动脉粥样硬化小鼠来检验如下假说,即晚期斑块中巨噬细胞 uPA 表达增加会导致类似于破裂人类斑块的组织学特征。
来自过表达巨噬细胞 uPA 的转基因小鼠或非转基因对照(均为载脂蛋白 E 缺陷型[apoE(-/-)])的骨髓被移植到 35 周龄 apoE(-/-)受者体内,8 至 13 周后检查无名动脉病变和主动脉。供体巨噬细胞在斑块帽旁的无名动脉病变和主动脉中聚集,增加了两个部位的 uPA 表达。接受过表达 uPA 的巨噬细胞移植的受者斑块内出血的发生率增加(61%比 13%;P=0.002),病变中纤维蛋白染色和纤维帽破裂也增加(两者均为 P=0.06)。uPA 过表达的巨噬细胞移植增加了主动脉基质金属蛋白酶活性(40%;P=0.02)。这种增加与基质金属蛋白酶-9 无关。
在 apoE(-/-) 小鼠的晚期斑块中,巨噬细胞 uPA 过表达导致斑块内出血和纤维帽破裂,这些特征与人类斑块破裂有关。uPA 过表达还增加了血管基质金属蛋白酶的活性。这些数据为连接小鼠中巨噬细胞 uPA 表达、基质金属蛋白酶活性和斑块破裂特征提供了一种机制。这些数据还表明,人类斑块中升高的斑块纤溶酶原激活物表达和纤溶酶原激活可能与斑块破裂和心血管事件有因果关系。